Omeros reported $4.93M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US USD 247K 80K
Alnylam Pharmaceuticals ALNY:US USD 41.08M 1.52M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Cytokinetics CYTK:US USD 6.8M 4M
Gilead Sciences GILD:US USD 227M 2M
Insmed INSM:US USD 3.35M 4K
Intercept Pharmaceuticals ICPT:US USD 5.24M 1.43M
Knight Therapeutics Inc GUD:CN CAD 1.48M 238K
Omeros OMER:US USD 4.93M 5K
Pacira Pharmaceuticals PCRX:US USD 9.86M 1.02M
Pfizer PFE:US USD 313M 2M
Regulus Therapeutics RGLS:US USD 175K 13K
Rockwell Medical RMTI:US USD 476K 9K
Sarepta Therapeutics SRPT:US USD 14.74M 1.29M
United Therapeutics UTHR:US USD 9.2M 3M
Vertex Pharmaceuticals VRTX:US USD 13.7M 900K